Your browser doesn't support javascript.
loading
Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience.
Alduaij, Waleed; McNamara, Caroline J; Schuh, Andre; Arruda, Andrea; Sukhai, Mahadeo; Kanwar, Nisha; Thomas, Mariam; Spiegel, Jay; Kennedy, James A; Stockley, Tracy; Tsui, Hubert; Devlin, Rebecca; Sibai, Hassan; Maze, Dawn; Schimmer, Aaron; Yee, Karen; Chan, Steven; Kamel-Reid, Suzanne; Gupta, Vikas.
Afiliación
  • Alduaij W; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • McNamara CJ; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Schuh A; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Arruda A; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Sukhai M; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Kanwar N; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Thomas M; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Spiegel J; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Kennedy JA; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Stockley T; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston MA, USA.
  • Tsui H; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Devlin R; Department of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.
  • Sibai H; Department of Laboratory Hematology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Maze D; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Schimmer A; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Yee K; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Chan S; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Kamel-Reid S; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Gupta V; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Hemasphere ; 2(3): e44, 2018 Jun.
Article en En | MEDLINE | ID: mdl-31723772
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Hemasphere Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Hemasphere Año: 2018 Tipo del documento: Article